Cary Street Partners Investment Advisory’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
CCM
Cary Street Partners Investment Advisory's THC Position: Q4 2023 in Review
Cary Street Partners Investment Advisory sold out of Tenet Healthcare (THC) in Q4 2023, closing a stake of 10 shares — an estimated $659 sold.
Cary Street Partners Investment Advisory first reported a position in THC in Q4 2022 and held it in 4 quarters. The position peaked at $814 in Q2 2023. 425 funds tracked by Wall St. Rank hold THC as of Q4 2023.
- Cary Street Partners Investment Advisory reported no remaining Tenet Healthcare position as of Q4 2023 after selling out during the quarter.
- Cary Street Partners Investment Advisory sold 10 Tenet Healthcare shares in Q4 2023, an estimated $659.
- Cary Street Partners Investment Advisory first reported a position in Tenet Healthcare in Q4 2022 and held it in 4 quarters.
- Cary Street Partners Investment Advisory's Tenet Healthcare position peaked at $814 in Q2 2023.
- 425 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2023.
Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.